Knowledge Distillery

Infections, including infection with SARS-CoV-2 (COVID-19), could alter the course of multiple sclerosis (MS). Previous studies assessing the effects…

There are concerns for safety regarding SARS-CoV-2 vaccines for patients with autoimmune neuromuscular disease. In this substudy of a prospective…

Demyelinating diseases including multiple sclerosis are associated with prior infectious exposures. In this article the authors assessed whether…

Messenger RNA (mRNA) vaccines provide robust protection against SARS-CoV-2 in healthy individuals. However, immunity after vaccination of patients…

The COVID-19 pandemic raised concern amongst clinicians that disease-modifying therapies (DMT), particularly anti-CD20 monoclonal antibodies (mAb) and…

In October 2020, the European Academy of Neurology (EAN) consensus statement for management of patients with neurological diseases during the…

Epidemiological studies showed that COVID-19 increases risk of Alzheimer's disease (AD). However, it remains unknown if there is a potential genetic…

Fatigue is a frequent and one of the most debilitating symptoms in post-COVID syndrome (PCS). Recently, the authors of this article proposed that…

This study investigated the rate of breakthrough SARS-CoV-2 infection and clinical outcomes in a cohort of multiple sclerosis (MS) patients who were…

An association between intercurrent viral respiratory infections and exacerbations of Multiple Sclerosis (MS) disease activity has been proposed by…

Coronavirus disease 2019 (COVID-19), a global pandemic, has infected approximately 10% of the world's population. This comprehensive review aims to…

There is a paucity of nationally representative data regarding the impact of COVID-19 on acute ischemic stroke (AIS) outcome. In this article the…